Tolgabide

Tolgabide
	File:Tolgabide-ifa.png
Systematic (IUPAC) name
	4-{[(Z)-(3-chloro-5-methyl-6-oxocyclohexa-2,4-dien-1-ylidene)(4-chlorophenyl)methyl]amino}butanamide
Clinical data
Routes of; administration	?
Legal status
Legal status	Uncontrolled;
Identifiers
CAS Number	86914-11-6
ATC code	none
PubChem	CID 5748792
ChemSpider	4678139
Chemical data
Formula	C18H18Cl2N2O2
Molar mass	365.25 g/mol[[Script error: No such module "String".]]
	Script error: No such module "collapsible list".

Script error: No such module "TemplatePar".Expression error: Unexpected < operator.

Tolgabide (SL-81.0142) is a drug which was patented by Synthélabo as an anticonvulsant but was never marketed.^[1] It is an analogue of progabide and acts similarly to it as a prodrug of GABA, and therefore as an indirect agonist of the GABA receptors.^[1]^[2]

References

Cite error: Invalid <references> tag; parameter "group" is allowed only.

Use <references />, or <references group="..." />